TY  - GEN
AU  - Mulloy,L L
AU  - Wright,F
AU  - Hall,M L
AU  - Moore,M
TI  - Simulect (basiliximab) reduces acute cellular rejection in renal allografts from cadaveric and living donors
SN  - 0041-1345
PY  - 1999///0415
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Basiliximab
KW  - Cadaver
KW  - Cyclosporine
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Female
KW  - Graft Rejection
KW  - prevention & control
KW  - Graft Survival
KW  - Histocompatibility Testing
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Kidney Transplantation
KW  - immunology
KW  - Living Donors
KW  - Male
KW  - Middle Aged
KW  - Recombinant Fusion Proteins
KW  - Retrospective Studies
KW  - Survival Analysis
KW  - Tissue Donors
KW  - United States
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase III; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/s0041-1345(98)02094-6
ER  -